Microneedle Immunotherapy

Microneedle Immunotherapy

• Although it is a fundamental therapy, the use of immunotherapy has been limited as it requires steady treatment for more than three years and needs to be subcutaneously or sublingually administered.

• Although allergen immunotherapy is a fundamental treatment, it requires a steady treatment period of 3 years or more. Therefore, its use has been limited compared to the existing subcutaneous or sublingual treatment methods.

• Microneedle patch is an immunotherapy with a novel drug delivery system. The patch delivers the allergen directly through the skin, making subcutaneous injection or sublingual administration unnecessary.

• Microneedle is a novel drug delivery system for immunotherapy. Unlike conventional subcutaneous or sublingual therapy, microneedles deliver the allergen directly through the skin.

• The skin has most immunocytes involved in immune reactions. Drug delivery through the skin using a microneedle patch can achieve the same result with less amount of drug and is an easy way to administer.

• Most of the immune cells involved in the immune response are present in the skin. Using a microneedle patch can achieve the same therapeutic result with a less amount of drug and it is very easy to use.

[wptb id=410]

• SCIT: Subcutaneous immunotherapy

• SLIT: Sublingual immunotherapy

• EPIT: Epicutaneous immunotherapy

• MNIT: Microneedle immunotherapy (Transdermal immunotherapy)